Grid Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Conferences Trial results

4 November 2024

SITC 2024 preview – duelling TIGIT duds

Failed trials of vibostolimab and domvanalimab will be unveiled at SITC late-breakers.

Subscribe to Grid Therapeutics